Chronic lymphocytic leukemia (CLL) is a mature B-cell lymphoid neoplasm characterized by the proliferation and accumulation of small CD5/CD19/CD23-positive lymphocytes in the blood, lymph nodes, spleen
Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (2017 WHO) has created several new provisional entities of high-grade B-cell lymphomas, including Burkitt-like lymphoma with 11q aberration
Hairy cell leukemia is a chronic B-cell lymphoid leukemia characterized by pancytopenia, splenomegaly, myelofibrosis and the presence in peripheral blood, bone marrow and spleen of atypical lymphoid cells with
CDRs (Complementaritydetermining regions) of V chains; wasting of enormous quantity of new Lymphoid cells in B-Cell development is also evolutionary and scientifically unbelievable and allowed us to propose
Complementarity-determining regions) of V chains; wasting of enormous quantity of new Lymphoid cells in B-Cell development is also evolutionary and scientifically unbelievable and allowed us to propose
genes. It has been recognised, in the 2016-revised WHO classification of lymphoid neoplasms, as “Highgrade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements”. We describe
that glucocorticoids may target a variety of immune system cells, including innate lymphoid cells, T- and B-cells, myeloid cells (granulocytes, macrophages, and dendritic cells), as well as non-immune
that glucocorticoids may target a variety of immune system cells, including innate lymphoid cells, T- and B-cells, myeloid cells (granulocytes, macrophages, and dendritic cells), as well as non-immune
BLOM with canceration. The infiltrated lymphocytes in BLOM comprise T- and B-cells. This indicates that the lymphoid tissue in BLOM is mucosa-associated lymphoid tissue and BLOM
lymphoid tissues (MALT), play an important role in producing secretory IgA (sIgA), the dominant antibody class in mucosal defense. This review discusses the interplay between T-cell and B-cell
Bronchial-associated lymphoid tissue (BALT) lymphoma is a distinct subgroup of low-grade B-cell extranodal non- Hodgkin’s lymphoma, classified as marginal-zone lymphoma. This study was performed
colon and tonsil, gastric plasmablastic lymphoma, gastric cancer with lymphoid stromal caused by EB virus combined with monoclonal B-cell lymphoproliferative disease, hepatoid adenocarcinoma with liver metastasis…
were in blast crisis at presentation. All the cases with lymphoid blast crisis were of B-cell phenotype. Molecular study for BCR-ABL1 was done for all the cases. JAK2V617F
distinct entity in the 2016 revised World Health Classification of lymphoid neoplasms under the rubric “High-grade B-cell lymphoma (HGBCL), with MYC and BCL2 and/or BCL6 translocations”. While
Hodgkinâ??s B-cell lymphomas (B-NHL) are aggressive lymphoid malignancies which develop in patients due to oncogenic activation, chemo-resistance and immune evasion. Tumor biopsies show that B
lymphocytes are seen diffusely throughout the specimen. Diffuse Large B-Cell Lymphoma (DLBCL) accounts for 20– 30% of all lymphoid malignancies. This subtype forms distinct morphological, molecular, and phenotypic…
entity included in the 2016 WHO classification of lymphoid neoplasms. Formerly known as “elderly lymphoma”, it is an aggressive B-cell lymphoma associated with chronic EBV infection and a poor
most common primary OAL is low-grade malignant extranodal marginal zone B-cell lymphoma (EMZL) of mucosa-associated lymphoid tissue (MALT) type. Though various classification and staging systems have been
Hodgkins lymphomas (NHLs) throughout the body. Marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) type ise the most common histological type involving the orbit. MALT lymphomas
cells) with a mature B- cell immunophenotype. Morphologically, the infiltration did not fit with lymphoplasmacytic lymphoma, as neither mast cells or plasmacytoid cells were present, nor did the small B ... cells…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.